Immediate Impact
3 standout
Citing Papers
Tumor immunotherapy resistance: Revealing the mechanism of PD-1 / PD-L1-mediated tumor immune escape
2024 Standout
Oesophageal cancer
2024 Standout
Works of Yuriy Ostapenko being referenced
Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial
2023 Standout
Patient-reported outcomes from the phase 3 HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma.
2022
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Yuriy Ostapenko | 113 | 128 | 63 | 6 | 188 | |
| Shu-Kui Qin | 175 | 122 | 43 | 8 | 259 | |
| Ester Simeone | 126 | 137 | 173 | 6 | 289 | |
| Evgeny Gotovkin | 113 | 149 | 74 | 4 | 199 | |
| Sam Li‐Sheng Chen | 120 | 141 | 142 | 6 | 281 | |
| Mark Sievert | 84 | 157 | 91 | 4 | 208 | |
| Kazuhiko Shioji | 105 | 188 | 150 | 11 | 271 | |
| Kanwal Pratap Singh Raghav | 157 | 115 | 60 | 8 | 233 | |
| Arnoud H. A. M. van Oijen | 124 | 160 | 204 | 7 | 297 | |
| Kevin K. Chang | 101 | 200 | 80 | 12 | 268 | |
| E Volpin | 99 | 35 | 65 | 5 | 151 |
All Works
Loading papers...